Scientists deploy CRISPR to preserve photoreceptors in mice

March 14, 2017
Green fluorescence indicating Nrl gene expression in mouse retina. Upper panel showing normal Nrl expression. Bottom panel showing reduced Nrl expression when knocked down with CRISPR. Credit: Zhijian Wu and Anand Swaroop

Silencing a gene called Nrl in mice prevents the loss of cells from degenerative diseases of the retina, according to a new study. The findings could lead to novel therapies for preventing vision loss from human diseases such as retinitis pigmentosa. The study was conducted by researchers at the National Eye Institute (NEI), part of the National Institutes of Health, and was published online today in Nature Communications.

The tissue in the back of the eye called the retina contains two types of cells that convert light into electrical signals sent to the brain. Rod photoreceptors enable vision in dim light, while cone photoreceptors enable and the ability to see in well-lit conditions. Genetic mutations affect mostly rods, leading to night blindness such as that seen with . However, because rods also provide vital structural and nutritional support to cones, rod dysfunction or death can lead to cone degeneration and blindness.

In a series of studies, Anand Swaroop, Ph.D., chief of NEI's Neurodegeneration and Repair Laboratory, and his team asked if saving rods could prevent the loss of cones, thus preserving daylight and color vision.

During development, Nrl determines whether a photoreceptor precursor cell becomes a rod or a cone. In previous studies, Swaroop and colleagues showed that mice engineered to lack the Nrl gene develop cone-only retinas. Other researchers showed that if Nrl expression is knocked out in rods of mature mice, the cells gain cone-like features and survive despite rod gene mutations.

"The evidence suggested to us that coaxing rods into becoming more cone-like by knocking out Nrl was a potential strategy for overriding mutations that would otherwise lead to rod degeneration," said Swaroop. "Consequently, the neighboring cones would remain functional and viable."

To test the strategy, the researchers used a new genome editing technology called CRISPR, which stands for clustered regularly interspaced short palindromic repeats. CRISPR is like a molecular pair of scissors that can be programmed to snip a specific DNA sequence with precision.

NEI postdoctoral research fellow and the study's first author, Wenhan Yu, Ph.D., developed a method for applying CRISPR in photoreceptors. His strategy uses an adeno-associated virus (AAV) as a carrier, or vector, to introduce CRISPR into . Yu tested this genome editing tool to remove the Nrl gene in wild-type mice and three different mouse models of . By measuring gene expression and examining the retinal cells, the researchers confirmed that rods became more cone-like, as predicted. Although these cone-like rods could not detect light, they survived and improved survival of their neighboring cones.

In all three mouse models, rod degeneration was prevented or slowed, although less benefit was achieved when the therapy was introduced in older animals. Importantly, the benefit was evident in all three models, regardless of the specific gene defect in the mouse.

"Unlike conventional gene therapy, in which a normal gene is introduced to replace the defective gene, this approach could treat retinal degeneration caused by a variety of mutant ," explained Zhijian Wu, Ph.D., head of the NEI Ocular Gene Therapy Core and senior author of the study.

More research is needed before the therapy is ready for testing in a clinical trial. The safety of CRISPR has yet to be established and information is needed about its possible adverse effects. Nevertheless, these findings provide proof of concept for CRISPR-based therapies for degenerative retinal diseases.

Explore further: Fighting blindness: Scientists bring a key protein into focus

More information: Yu W, Mookherjee S, Chaitankar V, Hiriyanna S, Kim JW, Brooks M, Ataeijiannati Y, Sun X, Dong L, Li T, Swaroop A, Wu Z. 2017. Nrl knockdown by AAV-delivered CRISPR/Cas9 prevents retinal degeneration in mice. Nature Communications.

Related Stories

Fighting blindness: Scientists bring a key protein into focus

March 6, 2017
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have discovered how a protein called α2δ4 establishes proper vision. Their research helps explain why mutations in the gene encoding α2δ4 lead ...

Altering eye cells may one day restore vision

January 25, 2013
(Medical Xpress)—Doctors may one day treat some forms of blindness by altering the genetic program of the light-sensing cells of the eye, according to scientists at Washington University School of Medicine in St. Louis.

Retinitis pigmentosa may be treated by reprogramming sugar metabolism

November 14, 2016
Columbia University Medical Center (CUMC) researchers have demonstrated that vision loss associated with a form of retinitis pigmentosa (RP) can be slowed dramatically by reprogramming the metabolism of photoreceptors, or ...

Retinitis pigmentosa gene discovery may reveal a new route to inherited blindness

November 24, 2016
Researchers at UCL Institute of Ophthalmology and Moorfields Eye Hospital with funding from Fight for Sight, in collaboration with a team from Baylor College of Medicine in the USA, have discovered a new retinitis pigmentosa ...

Eye's recycling process key to seeing color, bright light

October 28, 2015
As many of us learned in high school science class, the retina's rods and cones allow us to see. Rods are for night vision, and cones operate in bright light and allow us to distinguish colors. But although scientists have ...

Recommended for you

Researchers report startling glaucoma protein discovery

October 20, 2017
A discovery in a protein associated with glaucoma was so unheard of that for over two years, researchers ran it through a gauntlet of lab tests and published a new research paper on it. The tests validated what they initially ...

Curve-eye-ture: How to grow artificial corneas

October 19, 2017
Scientists at Newcastle University, UK, and the University of California have developed a new method to grow curved human corneas improving the quality and transparency - solely by controlling the behaviour of cells in a ...

Clinical study success for novel contact lens device aimed to improve glaucoma treatment

October 19, 2017
A novel contact lens device developed by University of Liverpool engineers to improve the treatment of glaucoma has been found to reliably track pressure changes in the eye and be wearable by people who took part in its first ...

Study indicates proof of concept for using a surrogate liquid biopsy to provide genetic profile of retinoblastoma tumors

October 12, 2017
Retinoblastoma is a tumor of the retina that generally affects children under 5 years of age. If not diagnosed early, retinoblastoma may result in loss of one or both eyes and can be fatal. Unlike most cancers that are diagnosed ...

Farsighted children struggle with attention, study finds

October 10, 2017
Farsighted preschoolers and kindergartners have a harder time paying attention and that could put them at risk of slipping behind in school, a new study suggests.

New drug reduces rate of progression of incurable eye disease

October 4, 2017
An international study including researchers from the Centre for Eye Research Australia (CERA) has found a way to slow the progression of dry age-related macular degeneration (AMD) - one of the most common causes of vision ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.